Life Science News

28 March 2003 - Flamel's CR technology to pump up GSK's pipeline

GlaxoSmithKline and Flamel Technologies reveal $45m licensing deal to develop new controlled release formulation GlaxoSmithKline, London UK and..  More >>

28 March 2003 - Genzyme beefs up Renagel® Production in Europe

EMEA approves Renagel® production at Genzyme’s new plant in Ireland - marks a new phase of expansion in capacity. The European Medicines Evaluation..  More >>

27 March 2003 - Diosynth withdraws from acquiring GSK's Montrose site

Akzo Nobel withdraws from negotiations to acquire Scottish API facility from GSK Akzo Nobel’s business Diosynth has decided to withdraw from negotiations..  More >>

24 March 2003 - Baxter to acquire ML Labs' Icodextrin manufacturing business

ML Laboratories plc has come to an agreement with Baxter Healthcare Limited that will see ML disposing of its Liverpool based Icodextrin manufacturing business..  More >>

01 March 2003 - New $11m custom pharma development expansion

Cambrex to provide pharma development services Cambrex Corporation, best known as a manufacturer of active pharmaceutical ingredients (APIs) for..  More >>

12 February 2003 - Revival of a vaccine against smallpox in France

France prepares for possible bioweapon attack A decree published in France’s Official Journal (decree n° 2003-109 dated February 11, 2003) envisages..  More >>

04 February 2003 - Lonza Biologics and Alexion Pharmaceuticals sign commercial biomanufacturing agreement

Alexion Pharmaceuticals, Inc. reveals it has concluded a large-scale product supply agreement with Lonza Biologics for the long term commercial manufacture of..  More >>

03 January 2003 - Novel treatment for arteriosclerosis in prospect

BioInvent to develop and commercialize new type of treatment for arteriosclerosis Bioinvent International AB, has acquired rights to develop antibody-based..  More >>

11 December 2002 - David Williams to head Aventis Pasteur

David Williams will take over as Chairman and General Manager on 1st January 2003. The Board of Directors of Aventis Pasteur has revealed that David J..  More >>

10 December 2002 - Bio/PharMOS 2003 enters the slipway at Monte Carlo

Europe’s Dedicated Event for Contract Pharma & Biotech Manufacturing Prepares for March 26-28 2003 Voyage Following the successful Bio/PharMOS..  More >>

10 December 2002 - Galen acquires Sarafem

Galen acquires rights to Sarafem Galen, the biopharmaceutical company based in Ulster with offices in New Jersey has acquired the rights to market..  More >>

10 December 2002 - New plant derived molecule opens way to 'metronomic' cancer therapy

New oral taxane in combination therapy could be more tolerable and effective Italian company Indena presented recent research data at the Symposium on..  More >>